文献速递糖尿病

利用多种可穿戴设备表征产后妊娠期糖尿病的代谢与昼夜节律特征

The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
PubMed 文献 · Diabetologia · 2024-11-12

这项前瞻性观察研究使用连续血糖监测、智能手机饮食日记、三轴加速度计及心率与心率变异性监测,在产后1-2个月(基线)及6个月后(随访)比较既往妊娠期糖尿病(GDM)女性(n=22)与糖代谢正常妊娠女性(n=15)。GDM组基线BMI、HbA1c和平均血糖波动幅度更高,餐后血糖下降更慢,血糖24小时节律振幅更低;较晚的昼夜节律时相与更高的空腹血糖及更低的血糖节律振幅相关。

要点

  • GDM组产后基线BMI、HbA1c和平均血糖波动幅度均高于非GDM组(均p≤0.05)。
  • 整合CGM与进食事件显示GDM组餐后血糖下降更慢(p=0.01),血糖24小时节律振幅更低(p=0.005)。
  • 较晚的睡眠中点、进食中点和心率峰值时间与更高空腹血糖及更低血糖节律振幅相关(均p≤0.05)。

核心结论

  • 研究显示GDM女性产后存在血糖变异性和24小时节律的差异,即使在临床认为血糖正常的女性中也是如此。
  • 作者认为结果为进一步干预提供了依据,干预方向包括改善血糖变异性和鼓励更早的日常行为模式,以减轻GDM的长期心脏代谢风险。

研究设计与样本

  • 前瞻性观察研究,使用连续血糖监测仪、智能手机饮食日记、三轴加速度计以及心率和心率变异性监测器,持续2周。
  • 比较既往妊娠GDM女性(GDM组,n=22,其中5例基于空腹血糖5.6-6.9 mmol/l(100-125 mg/dl)和/或HbA1c 39-47 mmol/mol(5.7-6.4%)定义的前驱糖尿病)与糖代谢正常妊娠女性(非GDM组,n=15),在产后1-2个月(基线)及6个月后(随访)评估。
  • 将基线及随访数据汇总入线性混合模型,量化血糖变量与可穿戴设备衍生的昼夜节律时相标志物之间的关系。

主要发现

  • 与非GDM组(n=15)相比,GDM组(n=22)基线BMI、HbA1c和平均血糖波动幅度更高(均p≤0.05)。
  • 整合CGM数据与进食事件显示,GDM组餐后血糖下降更慢(p=0.01),尽管碳水化合物摄入比例更低、平均血糖水平相似,且基础血糖24小时节律振幅更低(p=0.005)。
  • 从比较中移除5例前驱糖尿病女性后,CGM衍生的变量差异持续存在。
  • 从基线到随访的纵向分析显示,两组空腹血糖均显著增加;CGM衍生指标从基线到随访无差异。
  • 较晚的昼夜节律时相(即睡眠中点、进食中点和心率峰值时间)与更高的空腹血糖和更低的基础血糖24小时节律振幅相关(均p≤0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Gestational diabetes mellitus (GDM) affects 14% of all pregnancies worldwide and is associated with cardiometabolic risk. We aimed to exploit high-resolution wearable device time-series data to create a fine-grained physiological characterisation of the postpartum GDM state in free-living conditions, including clinical variables, daily glucose dynamics, food and drink consumption, physical activity, sleep patterns and heart rate. METHODS: In a prospective observational study, we employed continuous glucose monitors (CGMs), a smartphone food diary, triaxial accelerometers and heart rate and heart rate variability monitors over a 2 week period to compare women who had GDM in the previous pregnancy (GDM group) and women who had a pregnancy with normal glucose metabolism (non-GDM group) at 1-2 months after delivery (baseline) and 6 months later (follow-up). We integrated CGM data with ingestion events recorded with the smartphone app MyFoodRepo to quantify the rapidity of returning to preprandial glucose levels after meal consumption. We inferred the properties of the underlying 24 h rhythm in the baseline glucose. Aggregating the baseline and follow-up data in a linear mixed model, we quantified the relationships between glycaemic variables and wearable device-derived markers of circadian timing. RESULTS: Compared with the non-GDM group (n=15), the GDM group (n=22, including five with prediabetes defined based on fasting plasma glucose [5.6-6.9 mmol/l (100-125 mg/dl)] and/or HbA1c [39-47 mmol/mol (5.7-6.4%)]) had a higher BMI, HbA1c and mean amplitude of glycaemic excursion at baseline (all p≤0.05). Integrating CGM data and ingestion events showed that the GDM group had a slower postprandial glucose decrease (p=0.01) despite having a lower proportion of carbohydrate intake, similar mean glucose levels and a reduced amplitude of the underlying glucose 24 h rhythm (p=0.005). Differences in CGM-derived variables persisted when the five women with prediabetes were removed from the comparison. Longitudinal analysis from baseline to follow-up showed a significant increase in fasting plasma glucose across both groups. The CGM-derived metrics showed no differences from baseline to follow-up. Late circadian timing (i.e. sleep midpoint, eating midpoint and peak time of heart rate) was correlated with higher fasting plasma glucose and reduced amplitudes of the underlying glucose 24 h rhythm (all p≤0.05). CONCLUSIONS/INTERPRETATION: We reveal GDM-related postpartum differences in glucose variability and 24 h rhythms, even among women clinically considered to be normoglycaemic. Our results provide a rationale for future interventions aimed at improving glucose variability and encouraging earlier daily behavioural patterns to mitigate the long-term cardiometabolic risk of GDM. TRIAL REGISTRATION: ClinicalTrials.gov no. NCT04642534.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Phillips NE, Mareschal J, Biancolin AD, et al. The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices. Diabetologia. 2024. PMID: 39531039. doi:10.1007/s00125-024-06318-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。